Quick Answer
Hesperidin Supplementation Vascular Function Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Adipose tissue expansion, immune cell infiltration, adipokine dysregulation, mitochondrial dysfunction, and increased reactive oxygen species generation collectively promote metabolic and vascular abnormalities including insulin resistance, fatty liver, vascular endothelial activation, and atherosclerosis (–).
Key Takeaways
- 01Adipose tissue expansion, immune cell infiltration, adipokine dysregulation, mitochondrial dysfunction, and increased reactive oxygen species generation collectively promote metabolic and vascular abnormalities including insulin resistance, fatty liver, vascular endothelial activation, and atherosclerosis (–). [Zhu Kun (2026)]
- 02Constructing an outcome hierarchy based on these complementary readouts better captures the pathological features associated with overweight and obesity than emphasizing a single inflammatory biomarker alone. [Zhu Kun (2026)]
- 03Experimental evidence suggests that hesperidin and its aglycone metabolite hesperetin may modulate inflammatory and oxidative pathways, providing biological plausibility for effects on inflammatory and oxidative stress biomarkers (–). [Zhu Kun (2026)]
- 041 4 Overweight and obesity are not merely anthropometric states but are commonly accompanied by low-grade chronic inflammation, redox imbalance, and metabolic tissue stress. [Zhu Kun (2026)]
The current Migaku evidence database contains 2 reusable source documents for Hesperidin Supplementation Vascular Function Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Adipose tissue expansion, immune cell infiltration, adipokine dysregulation, mitochondrial dysfunction, and increased reactive oxygen species generation collectively promote metabolic and vascular abnormalities including insulin resistance, fatty liver, vascular endothelial activation, and atherosclerosis (–). [Zhu Kun (2026); evidence level 1]
- Constructing an outcome hierarchy based on these complementary readouts better captures the pathological features associated with overweight and obesity than emphasizing a single inflammatory biomarker alone. [Zhu Kun (2026); evidence level 1]
- Experimental evidence suggests that hesperidin and its aglycone metabolite hesperetin may modulate inflammatory and oxidative pathways, providing biological plausibility for effects on inflammatory and oxidative stress biomarkers (–). [Zhu Kun (2026); evidence level 1]
- 1 4 Overweight and obesity are not merely anthropometric states but are commonly accompanied by low-grade chronic inflammation, redox imbalance, and metabolic tissue stress. [Zhu Kun (2026); evidence level 1]
- Physical training reduced the body weight gain and fat accumulation and modulated the oxidative status by increasing superoxide dismutase activity and total antioxidant capacity and reducing lipid peroxidation. [Gonçalves TT (2018); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Effects of hesperidin supplementation on inflammation and oxidative stress in overweight or obese individuals: a systematic review and meta-analysis of randomized controlled trials
- Effects of glucosyl-hesperidin and physical training on body weight, plasma lipids, oxidative status and vascular reactivity of rats fed with high-fat diet.